NCT07436663 2026-02-27
SGLT2i/DPPi
Tanta University
Phase 4 Not yet recruiting
Clinical Trials
15 trialsNCT07365592 2026-01-26
Neo-CD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Not yet recruiting
NCT07003542 2025-08-11
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Case Comprehensive Cancer Center
Phase 2 Recruiting
NCT06587698 2024-09-19
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
Peking University Third Hospital
Phase NA Recruiting
NCT05895201 2024-04-29
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
Indiana University
Phase 1/2 Withdrawn
NCT05972928 2023-08-02
Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients
Beni-Suef University
Phase 2/3 Unknown
NCT04268563 2021-03-22
Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
Shahid Beheshti University of Medical Sciences
Phase 1/2 Unknown
NCT04298684 2020-09-11
METNODTHYR
Centre Hospitalier Universitaire de la Guadeloupe
Phase 4 Unknown
NCT02122380 2020-05-08
The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Vanderbilt University Medical Center
Phase 4 Completed
NCT01720264 2019-01-08
Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
Indiana University
Phase 2 Completed
NCT02294084 2018-07-16
Sita01
Leiden University Medical Center
Phase 4 Completed
NCT02941445 2016-10-21
Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
University Medical Centre Ljubljana
Phase 4 Completed
NCT02475499 2016-03-14
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Completed
NCT02493959 2015-07-10
Degradation of the Anorexic Hormone Peptide YY
Hvidovre University Hospital
Phase EARLY_PHASE1 Completed
NCT01588587 2012-10-19
DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients
Nagaoka Red Cross Hospital
Unknown